L-ARG/NO pathway contributes to LPS-induced hyporeactivity in rat mesenteric vascular bed: Effect of no-synthase inhibitors

1995 ◽  
Vol 31 ◽  
pp. 63 ◽  
Author(s):  
M. Potenza ◽  
M. Serio ◽  
M. Montagnani ◽  
G. Mansi ◽  
S. Pece ◽  
...  
Hypertension ◽  
1997 ◽  
Vol 30 (5) ◽  
pp. 1260-1266 ◽  
Author(s):  
Hunter C. Champion ◽  
Philip J. Kadowitz

Author(s):  
Hyun J. Lee ◽  
Silvana M. Cantú ◽  
María Álvarez Primo ◽  
Horacio A. Peredo ◽  
Adriana S. Donoso ◽  
...  

1994 ◽  
Vol 266 (6) ◽  
pp. H2416-H2422 ◽  
Author(s):  
D. Y. Cheng ◽  
B. J. DeWitt ◽  
T. J. McMahon ◽  
P. J. Kadowitz

The comparative effects of the nitric oxide (NO) synthase inhibitors N omega-nitro-L-arginine (L-NNA), N omega-nitro-L-arginine methyl ester (L-NAME), and N omega-nitro-L-arginine benzyl ester (L-NABE) on baseline tone and on vasodilator responses to acetylcholine (ACh), bradykinin (BK), and substance P (SP) were compared in the pulmonary vascular bed of the cat under constant flow conditions. After administration of the NO synthase inhibitors in intravenous doses of 100 mg/kg, the increase in lobar arterial pressure and the attenuation of vasodilator responses to ACh, BK, and SP were similar, whereas responses to adenosine and felodipine, endothelium-independent vasodilator agents, were not altered. In addition to inhibiting responses to ACh, BK, and substance P, the NO synthase inhibitors enhanced vasodilator responses to S-nitroso-N-acetylpenicillamine and NO. Moreover, atropine inhibited pulmonary vasodilator responses to ACh but not to SP or BK, and L-NAME or L-NABE had no effect on the decrease in heart rate in response to efferent vagal stimulation, a muscarinic receptor-mediated response that is independent of NO release. The similar inhibitory effects of L-NNA, L-NAME, and L-NABE on vasodilator responses to ACh, BK, and SP suggest that the L-arginine analogue, L-NNA, as well as the methyl and benzyl esters of L-NNA are useful probes for studying NO-mediated endothelium-dependent responses in the pulmonary vascular bed of the intact-chest cat.(ABSTRACT TRUNCATED AT 250 WORDS)


Peptides ◽  
2001 ◽  
Vol 22 (9) ◽  
pp. 1427-1434 ◽  
Author(s):  
Hunter C. Champion ◽  
Robert L. Pierce ◽  
Trinity J. Bivalacqua ◽  
William A. Murphy ◽  
David H. Coy ◽  
...  

1994 ◽  
Vol 266 (3) ◽  
pp. H952-H958 ◽  
Author(s):  
J. J. Hwa ◽  
L. Ghibaudi ◽  
P. Williams ◽  
M. Chatterjee

The relative contributions of nitric oxide (NO) to in vitro relaxation responses elicited by acetylcholine (ACh) were compared in vessels of different sizes from the rat mesenteric vascular bed. ACh elicited an endothelium-dependent relaxation in phenylephrine-contracted superior mesenteric arteries (SMA, unstretched luminal diam 650 microns), which was blocked by compounds that inhibited NO, such as hemoglobin (10 microM), methylene blue (10 microM), and NG-monomethyl-L-arginine (1 mM). In contrast, the endothelium-dependent relaxation induced by ACh in phenylephrine-contracted mesenteric resistance arteries (MRA, unstretched luminal diam 200 microns) was not blocked by hemoglobin, methylene blue, or NG-monomethyl-L-arginine. KCl (25 mM) partially inhibited the ACh-dependent relaxation in MRA. Furthermore, the ACh-dependent relaxation in MRA was selectively inhibited by the Ca(2+)-activated K+ channel blocker charybdotoxin (0.1 microM). In contrast, the ATP-sensitive K+ channel blocker glibenclamide (50 microM) did not block the ACh-dependent relaxation in MRA. We conclude that 1) NO is a major component of the ACh-dependent relaxation in SMA and 2) the ACh-dependent relaxation of MRA is resistant to NO inhibitors but sensitive to a Ca(2+)-activated K+ channel blocker. This suggests that an endothelium-derived hyperpolarization factor may be involved in the relaxation of MRA.


1978 ◽  
Vol 235 (3) ◽  
pp. H326-H332 ◽  
Author(s):  
B. M. Chapnick ◽  
L. P. Feigen ◽  
A. L. Hyman ◽  
P. J. Kadowitz

Life Sciences ◽  
2000 ◽  
Vol 67 (11) ◽  
pp. 1369-1379 ◽  
Author(s):  
D. Misurski ◽  
R. Tatchum-Talom ◽  
J.R. McNeill ◽  
V. Gopalakrishnan

1986 ◽  
Vol 251 (5) ◽  
pp. H885-H889 ◽  
Author(s):  
J. St-Louis ◽  
A. Parent ◽  
R. Lariviere ◽  
E. L. Schiffrin

The effect of treatment with estrogens on the biological activity of arginine8 vasopressin (AVP) in the in vitro perfused mesenteric vascular bed and on the binding characteristics of [3H]AVP on membranes prepared from the same vascular bed was studied. Female rats treated with estradiol (400 micrograms/24 h sc), compared with ovariectomized rats, had an increase in the maximum response to AVP (from 128 +/- 3 to 153 +/- 3 mmHg) in the perfused preparation and an increase in the density of AVP binding sites (from 402 to 732 fmol/mg protein) in the membrane preparation. In male rats, the injection of estradiol increased the maximum response to AVP (from 109 +/- 4 to 137 +/- 3 mmHg) and the density of AVP binding sites (from 289 to 519 fmol/mg protein). The effective concentration producing 50% of maximum response of AVP in the perfused preparation was higher in male than in female rats, while the Kd in the binding experiments was similar in the four experimental groups. Our results show that estrogens upregulate the number of AVP binding sites, leading to an increase in the pressor response to AVP in the rat mesenteric vascular bed.


Sign in / Sign up

Export Citation Format

Share Document